SCHEMBL30099366

SCHEMBL30099366

Cc1cccc(-c2nn(C3CCCCO3)cc2I)n1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 10/20 0.38
ATR Q13535 1/20 0.38
ABL1 P00519 1/20 0.36
MAPK14 Q16539 4/20 0.36
DRD4 P21917 2/20 0.36
KDR P35968 2/20 0.36
RIPK2 O43353 1/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.35
TGFBR2 P37173 1/20 0.34
CCR1 P32246 1/20 0.34
CCR8 P51685 1/20 0.34
THRB P10828 3/20 0.34
MAP3K5 Q99683 2/20 0.33
KDM5B Q9UGL1 1/20 0.33
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30744831 0.86 TGFBR1 (0.38) TGFBR1ATRABL1MAPK14DRD4
SCHEMBL30744730 0.78 CCR1 (0.41) TGFBR1ATRDRD4HTR1ADRD2
SCHEMBL22325063 0.76 GAA (0.38) ABL1KDM5BCYP4F2CYP4A11
SCHEMBL30099354 0.75 TGFBR1 (0.52) TGFBR1ABL1MAPK14KDRRIPK2
SCHEMBL30099359 0.75 TGFBR1 (0.45) TGFBR1ATRABL1MAPK14KDR
SCHEMBL20893676 0.74 ATR (0.41) TGFBR1ATRDRD4HTR1ADRD2
SCHEMBL23389890 0.74 TGFBR1 (0.39) TGFBR1ATRABL1MAPK14KDR
SCHEMBL29796700 0.74 TGFBR1 (0.39) TGFBR1ATRABL1MAPK14KDR
SCHEMBL23389924 0.73 TGFBR1 (0.46) TGFBR1ATRABL1MAPK14KDR
SCHEMBL29796515 0.73 TGFBR1 (0.46) TGFBR1ATRABL1MAPK14KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022251359-A1 BICYCLIC INHIBITORS OF ALK5 AND METHODS OF USE THERAVANCE BIOPHARMA R&D IP, LLC (US) 2022-12-01 WO disclosed